Refresh

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 25 Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22

Sales

5,637.89 5,284.68 5,059.58 5,812.58 5,510.22

Operating profit

1,521.04 1,219.81 967.56 538.16 722.88

Interest

117.45 102.76 68.28 27.05 8.45

Gross profit

1,646.88 1,305.03 1,061.24 605.68 1,259.09

EPS (Rs)

19.64 14.92 12.83 4.89 17.78
Half yearly  results in details
Sep ' 25 Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22

Other income

243.29 187.98 161.96 94.57 544.66

Stock adjustment

139.75 -66.81 -43.37 -81.17 28.86

Raw material

2,584.17 2,742.92 2,893.59 3,201.56 2,838.27

Power and fuel

- - - - -

Employee expenses

577.34 524.81 483.57 816.81 779.99

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

815.59 863.95 758.23 1,337.22 1,140.22

Provisions made

- - - - -

Depreciation

141.51 135.04 125.42 211.85 202.42

Taxation

364.87 303.42 238.17 107.04 -60.01

Net profit / loss

1,140.50 866.57 751.69 286.79 1,041.97

Extra ordinary item

- - 54.04 - -74.71

Prior year adjustments

- - - - -

Equity capital

58.08 58.08 58.59 58.59 58.59

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

26.98 23.08 19.12 9.26 13.12

GPM (%)

28.00 23.85 20.32 10.25 20.79

NPM (%)

19.39 15.83 14.40 4.85 17.21
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com